HomeNDC LookupRxCUI directory › RxCUI 2380265

0.5 UNT Doses 3 ML insulin lispro-aabc 100 UNT/ML Pen Injector — RxCUI 2380265

RxNorm drug concept · Semantic clinical drug
RxCUI 2380265 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 9 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2380265
Official name0.5 UNT Doses 3 ML insulin lispro-aabc 100 UNT/ML Pen Injector
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asinsulin lispro-aabc 100 UNT/ML per 3 ML Pen Injector, 0.5 UNT Doses; insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector, 0.5 UNT Doses
FDA products mapped6
Package NDCs mapped9
Reported Medicaid activity (SDUD)14,049 prescriptions · 37 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Insulin Lispro Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Insulin lispro is a fast-acting insulin that helps your body manage blood sugar around mealtimes. It works by helping your muscles and fat cells absorb glucose from your blood, whi...
  • What exactly does insulin lispro do, and why did my doctor prescribe it?
  • For subcutaneous injections, you should inject insulin lispro within 15 minutes before a meal or immediately after a meal. Because it acts quickly, timing really matters — injectin...
  • When exactly should I inject this insulin — before or after I eat?
📖 Read our full Insulin Lispro Injection guide →

🕸️ Concept Web — How 0.5 UNT Doses 3 ML insulin lispro-aabc 100 UNT/M... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.5 UNT Doses 3 ML insulin lispro-aabc 100 UNT/ML Pen Injector RxCUI 2380265

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Insulin lispro 86009
    • Insulin lispro-aabc 2376838
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lyumjev 2380232
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Insulin lispro Pen Injector 1652238
    • Insulin lispro-aabc Pen Injector 2647140
    • Insulin lispro Injectable Product 1157461
    • Insulin lispro-aabc Injectable Product 2660410
    • Insulin lispro Pen Injector [Lyumjev] 2380240
    • Insulin lispro-aabc Pen Injector [Lyumjev] 2657497
    • Lyumjev Injectable Product 2380235
    • Pen Injector 1649571
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Insulin lispro-aabc 100 UNT/ML SCDC · 2380230
  • Insulin lispro Pen Injector SCDF · 1652238
  • Insulin lispro-aabc Pen Injector SCDFP · 2647140
  • Insulin lispro Injectable Product SCDG · 1157461
  • Insulin lispro-aabc Injectable Product SCDGP · 2660410

Brand-Name Concepts

📦 FDA Products & Package NDCs

6 products · 9 package NDCs
9 package NDCs map to RxCUI 2380265 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00002-7726-05 5 CARTRIDGE in 1 CARTON (0002-7726-05) / 3 mL in 1 CARTRIDG... LYUMJEV Eli Lilly and Company 2020-06-15
00002-7728-01 1 VIAL, MULTI-DOSE in 1 CARTON (0002-7728-01) / 10 mL in 1... LYUMJEV Eli Lilly and Company 2020-06-15
00002-7728-99 1 VIAL, MULTI-DOSE in 1 CARTON (0002-7728-99) / 10 mL in 1... LYUMJEV Eli Lilly and Company 2020-06-15
00002-8207-05 5 SYRINGE in 1 CARTON (0002-8207-05) / 3 mL in 1 SYRINGE (0... LYUMJEV KwikPen Eli Lilly and Company 2020-06-15
00002-8207-61 1 SYRINGE in 1 CARTON (0002-8207-61) / 3 mL in 1 SYRINGE LYUMJEV KwikPen Eli Lilly and Company 2020-06-15
00002-8228-27 2 SYRINGE in 1 CARTON (0002-8228-27) / 3 mL in 1 SYRINGE (0... LYUMJEV KwikPen Eli Lilly and Company 2020-06-15
00002-8235-05 5 SYRINGE in 1 CARTON (0002-8235-05) / 3 mL in 1 SYRINGE (0... LYUMJEV Tempo Pen Eli Lilly and Company 2022-09-29
00002-8235-99 1 SYRINGE in 1 CARTON (0002-8235-99) / 3 mL in 1 SYRINGE LYUMJEV Tempo Pen Eli Lilly and Company 2024-01-10
00002-8351-05 5 SYRINGE in 1 CARTON (0002-8351-05) / 3 mL in 1 SYRINGE (0... LYUMJEV Junior KwikPen Eli Lilly and Company 2020-06-15
Observed labelers: Eli Lilly and Company (9) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1813 Lyumjev for insulin pump use 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.